Aim 3 Particle Swarm Optimization PIGD

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT05934747
Status
Recruiting
Apply to this trial

Conditions

  • Parkinson's Disease and Parkinsonism

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • DBS — DEVICE
    Deep Brain Stimulation

Study Details

In Parkinson's disease (PD) patients undergoing standard-of-care Deep Brain Stimulation (DBS) therapy, to compare the effect on Parkinson's symptoms of two different neurostimulator settings designed to differ from each other as much as possible with respect to how much they activate two different neuroanatomical structures: the axonal pathway from Globus Pallidus (GP) to Pedunculopontine Nucleus (PPN), and the axonal pathway from PPN to GP.

Key Dates

Start date
Mar 19, 2024
Status verified
May 2026
Primary completion
Jun 1, 2028
Completion
Jan 5, 2030

Study Design

Enrollment
30 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Unified Parkinson's Disease Rating Scale Movement Disorders Society revision, MDS-UPDRS [ Time Frame: 1 hour and 2 weeks after intiating stimulation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneapolisMinnesota55414-

Find similar trials in Minneapolis, MN

By research site
University of Minnesota· Minneapolis, MN

Related Studies